Zura Bio Limited (94E.F) Comparison with companies in other sectors?

Zura Bio Limited has a share price of 61.87M. You can analyze Zura Bio Limited (94E.F) competitors across different market sectors through stock heatmaps.

What are 94E.F's NET and operating margins?

Zura Bio Limited (94E.F) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does 94E.F's earnings per share (EPS) trend reflect its financial momentum?

Zura Bio Limited (94E.F) EPS is -0.67 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Zura Bio Limited is -1.93, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Zura Bio Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Zura Bio Limited like P/E which is -2.13, P/B which is 0.99, and PEG which is 0.06. Compare them with sector averages to evaluate if the stock is priced fairly.

Zura Bio Limited

94E.F•XETRA

Healthcare

Biotechnology

€1.29

€0.05(4.03%)

Zura Bio Limited (94E.F) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.67

P/E Ratio

-1.93

ROE

-0.43%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$79.82M

Shares OutstandingTotal number of shares issued

$61.87M

Book Value/ShareNet worth per share

$1.63

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.67

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

-43.35%

ROAReturn on total assets

-37.35%

ROCEReturn on capital employed

-43.63%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.37

Cash/ShareCash and equivalents per share

$1.83

FCF YieldFree cash flow as percentage of market cap

-37.53%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for 94E.FFinancial Ratios Analysis details for 94E.F are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 94E.FSector Benchmarking details for 94E.F are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Zura Bio Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Zura Bio Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Zura Bio Limited's unique business strengths and challenges.

Key Financial Metrics for Zura Bio Limited

For Zura Bio Limited, essential financial indicators include EPS -0.67, PE -1.93, and ROE -0.43. These key ratios reveal insights into Zura Bio Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Zura Bio Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Zura Bio Limited

Metrics like Net Margin - and ROA -37.35% shed light on how well Zura Bio Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Zura Bio Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Zura Bio Limited

Using ratios such as P/B Ratio 0.99 and PEG Ratio 0.06, investors can assess whether Zura Bio Limited is appropriately valued based on its financials and growth potential. These figures, combined with Zura Bio Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Zura Bio Limited

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $-0.37, provide a snapshot of Zura Bio Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Zura Bio Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Zura Bio Limited

Investing in Zura Bio Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Zura Bio Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;